Clinical Trial Update: A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of E-islet 01 in participants with Type 1 diabetes and impaired hypoglycemic awaren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Hypoglycemia Unawareness
• Type 1 Diabetes Mellitus

Drugs mentioned

• E-islet 01

Snippet

Sponsor: EndoCell Therapeutics, Inc. | Conditions: Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness | Phase 1, Phase 2 | Status: RECRUITING